+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptor

Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptor

Plos One 9(8): E104338

In cardiac muscle, the release of calcium ions from the sarcoplasmic reticulum through ryanodine receptor ion channels (RyR2s) leads to muscle contraction. RyR2 is negatively regulated by calmodulin (CaM) and by phosphorylation of Ca2+/CaM-dependent protein kinase II (CaMKII). Substitution of three amino acid residues in the CaM binding domain of RyR2 (RyR2-W3587A/L3591D/F3603A, RyR2ADA) impairs inhibition of RyR2 by CaM and results in cardiac hypertrophy and early death of mice carrying the RyR2ADA mutation. To test the cellular function of CaMKII in cardiac hypertrophy, mutant mice were crossed with mice expressing the CaMKII inhibitory AC3-I peptide or the control AC3-C peptide in the myocardium. Inhibition of CaMKII by AC3-I modestly reduced CaMKII-dependent phosphorylation of RyR2 at Ser-2815 and markedly reduced CaMKII-dependent phosphorylation of SERCA2a regulatory subunit phospholamban at Thr-17. However the average life span and heart-to-body weight ratio of Ryr2ADA/ADA mice expressing the inhibitory peptide were not altered compared to control mice. In Ryr2ADA/ADA homozygous mice, AC3-I did not alter cardiac morphology, enhance cardiac function, improve sarcoplasmic reticulum Ca2+ handling, or suppress the expression of genes implicated in cardiac remodeling. The results suggest that CaMKII was not required for the rapid development of cardiac hypertrophy in Ryr2ADA/ADA mice.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 053863564

Download citation: RISBibTeXText

PMID: 25093823

Related references

Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules. American Journal of Physiology. Heart and Circulatory Physiology 300(6): H2187-H2195, 2011

mTOR signaling in mice with dysfunctional cardiac ryanodine receptor ion channel. Journal of Receptor, Ligand and Channel Research 8: 43-51, 2015

The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice. Biochemical Journal 461(1): 99-106, 2014

Cardiac hypertrophy and arrhythmia in mice induced by a mutation in ryanodine receptor 2. Jci Insight 5, 2019

CaMKII regulation of the cardiac ryanodine receptor and sarcoplasmic reticulum calcium release. Heart Rhythm 8(2): 323-325, 2011

Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides. Cardiovascular Research 101(1): 165-174, 2014

Function of the CaMKII-ryanodine receptor signaling pathway in rabbits with left ventricular hypertrophy and triggered ventricular arrhythmia. World Journal of Emergency Medicine 3(1): 65-70, 2012

IL-6/STAT3 signaling in mice with dysfunctional type-2 ryanodine receptor. Jak-Stat 4(4): E1158379, 2015

CaMKII phosphorylation of cardiac ryanodine receptor encodes signal for positive force-frequency relationship Defect in heart failure. Biophysical Journal 86(1): 107a, 2004

Transgenic mice with cardiac-specific inhibition of GRK3 display phenotype with cardiac hypertrophy and alpha1-adrenergic receptor hyper-responsiveness. Circulation 108(17 Supplement): IV-289, October 28, 2003

Cardiac hypertrophy associated with impaired regulation of cardiac ryanodine receptor by calmodulin and S100A1. American Journal of Physiology. Heart and Circulatory Physiology 305(1): H86-H94, 2013

Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice. Journal of Biological Chemistry 291(6): 2583-2600, 2016

Chronic CaMKII inhibition reverses cardiac function and cardiac reserve in HF mice. Life Sciences 2019, 2019

Targeted disruption of ryanodine receptor type 2 in the heart suppresses pressure overload-induced cardiac hypertrophy but impairs cardiac functions. European Heart Journal 24(Abstract Supplement): 12, August-September, 2003

Cyclosporin A may attenuate cardiac hypertrophy in NCX1 transgenic mice. FASEB Journal 15(4): A480, March 7, 2001